Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 31% ± 10% | |
ciliated cell | 4 studies | 24% ± 8% | |
hematopoietic precursor cell | 3 studies | 23% ± 4% | |
endothelial cell | 3 studies | 18% ± 2% | |
GABAergic neuron | 3 studies | 24% ± 4% | |
glutamatergic neuron | 3 studies | 32% ± 6% | |
goblet cell | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2452.40 | 1444 / 1445 | 100% | 55.45 | 183 / 183 |
intestine | 100% | 2345.50 | 966 / 966 | 100% | 70.62 | 526 / 527 |
liver | 100% | 6024.08 | 226 / 226 | 100% | 50.97 | 405 / 406 |
stomach | 100% | 1856.29 | 358 / 359 | 100% | 60.48 | 286 / 286 |
lung | 100% | 2329.88 | 577 / 578 | 100% | 56.34 | 1153 / 1155 |
breast | 100% | 2641.86 | 459 / 459 | 100% | 53.98 | 1114 / 1118 |
uterus | 100% | 2450.10 | 170 / 170 | 100% | 62.73 | 457 / 459 |
ovary | 100% | 2661.70 | 180 / 180 | 100% | 36.56 | 428 / 430 |
bladder | 100% | 2882.62 | 21 / 21 | 99% | 59.65 | 501 / 504 |
prostate | 100% | 2225.27 | 245 / 245 | 99% | 41.24 | 499 / 502 |
thymus | 100% | 2206.66 | 653 / 653 | 99% | 62.82 | 601 / 605 |
pancreas | 100% | 1417.73 | 327 / 328 | 99% | 49.11 | 177 / 178 |
kidney | 100% | 1816.51 | 89 / 89 | 98% | 38.68 | 885 / 901 |
skin | 100% | 4411.04 | 1809 / 1809 | 97% | 44.89 | 460 / 472 |
brain | 96% | 1037.41 | 2527 / 2642 | 100% | 29.56 | 704 / 705 |
adrenal gland | 100% | 1723.29 | 257 / 258 | 92% | 28.02 | 212 / 230 |
adipose | 100% | 2994.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2142.47 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 65.41 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.99 | 1 / 1 |
blood vessel | 100% | 1679.61 | 1330 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3376.31 | 906 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 1003.87 | 831 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 28.32 | 77 / 80 |
lymph node | 0% | 0 | 0 / 0 | 90% | 23.35 | 26 / 29 |
muscle | 82% | 671.71 | 659 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0032933 | Biological process | SREBP signaling pathway |
GO_0045540 | Biological process | regulation of cholesterol biosynthetic process |
GO_0036503 | Biological process | ERAD pathway |
GO_0045717 | Biological process | negative regulation of fatty acid biosynthetic process |
GO_0045541 | Biological process | negative regulation of cholesterol biosynthetic process |
GO_0045121 | Cellular component | membrane raft |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0015485 | Molecular function | cholesterol binding |
GO_0005515 | Molecular function | protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
Gene name | ERLIN1 |
Protein name | Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1) (Protein KE04) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1) (SPFH domain-containing protein 1) Erlin (SPFH domain-containing protein) (Endoplasmic reticulum lipid raft-associated protein) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein) |
Synonyms | C10orf69 KEO4 SPFH1 KE04 |
Description | FUNCTION: Component of the ERLIN1/ERLIN2 complex which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway . Binds cholesterol and may promote ER retention of the SCAP-SREBF complex . .; FUNCTION: (Microbial infection) Required early in hepatitis C virus (HCV) infection to initiate RNA replication, and later in the infection to support infectious virus production. . FUNCTION: Mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. . |
Accessions | O75477 ENST00000407654.7 B0QZ43 ENST00000421367.7 ENST00000370408.2 |